Objective: To understand the feasibility of recruiting people with advanced cancer into a randomised controlled trial of acceptance and commitment therapy (ACT) vs a standardised talking control (TC) and delivering ACT to this population; to explore the acceptability of outcome measures and generate normative data. 
| INTRODUCTION
In the United Kingdom, the National Institute for Clinical and Care
Excellence recommends that people with advanced illnesses should have their psychological needs met. 1 Acceptance and commitment therapy (ACT) has shown promise in a range of populations. 2 
ACT involves key processes that include helping people to work towards doing what is important to them (values) through building up resilience
to uncomfortable experiences such as thoughts and feelings (acceptance). 2 Increased acceptance is associated with decreased psychological suffering 3 and facilitates engagement with life despite limitations imposed by illness. 4 [Correction added on 21 January 2019, after first online publication: The details of funder "Marie Curie core grant funding, grant: MCCC-FPO-16-U" were inadvertently omitted, and have been added in this version.]
Whilst ACT may be beneficial for a range of psychological disorders, studies in life threatening illnesses are limited 5 ; only one trial has been identified for people with advanced (ovarian) cancer, 6 which suggested that ACT, compared with cognitive behavioural therapy (CBT) type intervention, was associated with improved quality of life (QoL) and decreased psychological distress. 6 Our study is based on previous work, which found an association between acceptance, psychological, and physical function in hospice day-therapy attendees (ie, those receiving palliative care); this work supported the rationale for an ACT based intervention for improving outcomes for those with palliative care needs. 7 As non-specific effects of therapy, such as therapist warmth, may contribute to improvement, a "talking control" (TC) was used as a comparison. 8 A TC also facilitates engagement, by minimising attrition through offering an intervention. 2 | METHOD
| Design
A feasibility, parallel group, two-armed, RCT of ACT versus TC.
| Study population
We aimed to recruit 54 participants based on pragmatic grounds to demonstrate feasibility in terms of recruitment, acceptance of randomisation, and likely attrition without the need for a power calculation. 10 People with advanced cancer attending day-therapy services, as in or out-patients, at three hospices in London, United Kingdom were considered for participation if they were aged 18 years or more with a diagnosis of advanced cancer not amenable to cure (ie, metastases at first diagnosis, subsequent recurrence, or lung cancer with or without metastases). People were excluded if they had a clinicianestimated survival of less than 4 months, an insufficient command of English to engage in a talking therapy, cognitive impairment, or were currently receiving CBT or ACT (please see protocol). 11 Potential participants were screened using the FACT-G (lower scores indicating lower functioning). 7 The mean FACT-G score in a cancer population is 80.9 (SD 17.0). 12 Therefore, a threshold of below 81 for entry into the trial was selected.
| Interventions, training, and supervision
Participants were offered eight weekly sessions of either ACT or TC that lasted up to an hour, and were adapted for use in advanced cancer. The sessions were delivered by one of six therapists over a period of up to 3 months, face-to-face in the hospice day-therapy unit, the participant's home or the therapist's clinic. Participants were given 3 months to complete their eight therapy session to allow for missed sessions due to reasons such as illness.
Therapists who delivered ACT also delivered TC to control for non-specific therapy factors. All therapists had at least 2 years of experience of using ACT and received two full days of training on ACT and TC in a palliative care population from the chief investigator (M.S.) and an experienced ACT therapist (M.W.); both were extensively trained in ACT. The training was supplemented with two half-day booster sessions during the study. There was fortnightly supervision from M.S. and M.W., which was also attended by a research nurse (S.D.) who provided support about working with a palliative care population.
The six therapists in this study were paid at sessional rates. Three out of six therapists already worked in cancer clinics and used ACT. All therapists took part in this study to improve their skills in ACT and to apply it to an advanced cancer population. We ensured at least one experienced therapist was based at each of the three hospices.
| ACT sessions and manual
The first four sessions of therapy aimed at helping the participant understand the concept of ACT and the psychopathological elements (eg, experiential avoidance and cognitive fusion) and ACT interventions (eg, increasing acceptance and defusion techniques). Once these components had been covered, the last sessions aimed at helping the participant practice these in order to become more psychologically flexible. Further details of the therapy sessions can be found in Table S1 .
The ACT manual, available on request, was a bespoke piece of work prepared by M.S. and M.W. targeting therapists with existing knowledge of ACT. It was informed by previous experts in ACT 2, 4 and adapted so ACT may be applied to people with advanced cancer. 
| TC sessions and manual
The TC involves a conversation led by the participant. The therapist gains the participants' interest and trust by being empathic and allowing them to feel heard, without commenting on the content of the material presented. It purposefully does not encourage exposure or avoidance of feared situations, it does not seek to problem solve, challenge beliefs, use mindfulness techniques, or explore different ways of behaving. Although there are some similarities to befriending, the TC is undertaken by the same therapist who also delivers the specified intervention, in this case ACT, but no lay equivalent of lay advice is given.
The TC manual was developed specifically for the project and is broadly based on the non-specific side effects of psychotherapy. The manual was based on previous research using a TC. 8 The TC manual provided examples and case studies of how to be empathic whilst remaining neutral and not offering advice. 
| Randomisation
Participants were randomised by a senior researcher (J.L.) to either ACT or TC using an independent web-based randomisation system (sealed envelope). 
| Ethics approval

| Outcomes
I. Feasibility of recruitment and retention:
• The recruitment target was 54 participants over 12 months.
• Retention of at least 60% of participants (ie, until the main follow-up time point of 3 months).
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• Rates of and reasons for attrition.
• The capacity to collect data from participants and hospice records.
II. Attitudes to and engagement with therapy and acceptability of outcome measures
• Acceptable feasibility criterion, adapted from previous research, 14 whereby 60% of participants were expected to engage at least "mostly with therapy," according to the fol- • Treatment preference was assessed at baseline using two questions: "how much would you hope to receive ACT?"
and "how much would you hope to receive TC?." 13 Scores ranged from 0 (Not at all) to 3 (Completely) for each item with higher scores indicting a preference for ACT or TC.
• Participants were asked to rate their expectation of ACT at baseline by recording on a scale of 1 (Not at all) to 10 (Completely) for how much they expected to change.
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• Satisfaction with therapy after 3 months was measured using a shortened version of the counselling questionnaire.
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• The amount of missing data was used as one indication of the acceptability of the outcome measures.
III. Quantitative measures
• Demographics
At baseline, age, gender, ethnicity, marital status, education level, previous psychiatric history, type of cancer, date of diagnosis, and the employment status of the main salaried person in the household were recorded.
• Functioning
The primary outcome was the FACT-G (version 4). It was selected as it has widely been used in people with advanced cancer and focuses on more than one aspect of pathology. 17 It comprises 27 items in four domains: physical well-being, social/family well-being, emotional wellbeing, and functional well-being. Each item is rated 0 to 4. The total score ranges from 0 to 108. A lower score indicates poorer functioning.
• Psychological distress
The Kessler Psychological Distress Scale (K10), 18 a validated 10-item scale, 7 rating each item 1 to 5, total score 10 to 50, with greater than or equal to 20 indicating psychological distress.
• Physical functioning Two tests of physical functioning were used 19 :
A. A 2-minute walking test-the distance in metres that participants were able to walk in 2 minutes.
B. A 1-minute sit-to-stand test-the numbers of times participants were able to stand up from a chair without using their arms in a minute.
• Acceptance commitment therapy process A. Acceptance
The Acceptance and Action Questionnaire II (AAQII) 20 : A validated 10-item measure, used in the preliminary study 7 to assess experiential avoidance and psychological inflexibility. Each item is scored from 1 to 7, total range of 10 to 70, where higher scores indicate greater psychological inflexibility.
B. Living according to one's values
The Valued Living Questionnaire (VLQ), 21 In an exploratory analysis, we estimated differences (with confidence intervals) in the main outcomes between the trial arms at 3 months. A linear regression adjusted for baseline values of the outcome and the stratification factor (centre) was used. The normality assumptions of the residuals were investigated using residual plots.
We also used a mixed effect model, using all patient data over the 6 months, to investigate the effect over time. Such models allow analysis of repeated outcome measurement data whilst taking into account the correlation between measurements from the same patient. All analyses were carried out as allocated and based on complete cases using the statistical software STATA version 14. Table 1 ). The characteristics of participants in both arms were similar except in the ACT arm where there were fewer people educated to diploma level (ie, completed two or more years at degree level or similar) and above.
3.2 | Feasibility
| Recruitment
We recruited 78% (42/54) of the target. The main barriers to achieving the recruitment target were limited availability of therapists, all eligible participants already taking part in the study, and restriction of the sample to those with advanced cancer.
| Follow-up
Data from 18/42 (43%) were available at 3 months (the primary end point), which missed our aim of 60% retention. Data from at least one follow-up were available in 30 out of 42 (71%) participants.
Reasons for attrition included death, deteriorating health, and loss to follow-up (see Figure 1) . One person felt the therapy was unsuitable.
At the primary time point (3 months), there was no statistical difference in attrition between the arms.
| Collecting participants' data
Collecting data on medication was limited as hospice notes were not easily accessible and omitted medication prescribed by general practitioners.
3. 
| Satisfaction with therapy
Of those followed up at 3 months, 5/6 (83%) ACT participants and 5/10 (50%) TC participants found the therapy useful, and 6/6 (100%) ACT and 6/10 (60%) TC participants found talking to the therapists easy. (see Table S2 ).
FIGURE 1 Consolidated Standards of Reporting Trials (CONSORT) flow diagram of participants
| Treatment preference
The treatment preference was a mean of 1.6 (SD = 1.2) for ACT and 1.3 (SD = 1.2) for TC, indicating no strong preference for receiving either ACT or TC at baseline.
| Expectation of ACT
Participants' expectancy of improving was a mean of 5.9 (SD = 2.5) for ACT and 5.6 (SD = 2.5) for TC. (Table 2 and Figure 2 ).
| Acceptability of measures
| Psychological distress
Psychological distress, measured using the Kessler 10, showed that at baseline, there was mild distress in both the ACT (mean = 26.3; SD = 7)
and TC (mean = 23.2; SD = 7.9) groups. At 3 months, psychological distress was mild for those in the ACT (mean = 22.1; SD = 7.9) group and absent for those in the TC (mean = 18.3; SD = 4.9) group. The adjusted mean difference at 3 months was 0.6 (CI, −7.25-8.53). (see Table 2 for all secondary outcomes).
| Physical functioning
Walking test, the mean at baseline was 78. 
| Process of ACT
In the ACT arm, the mean score on the AAQ-II was 34.1 (SD 10.2) at baseline and 31.1 (SD 8.0) at 3 months. In the TC arm, the score was 31.5 (SD 9.8) at baseline and at 3 months was also 30.0 (SD 5.6).
For the VLQ, the adjusted mean difference between ACT and TC was 0.22 (95% CI, −19.42-19.87) at 3 months.
| Economic
For the EQ-5D-5L, the adjusted mean difference at 3 months between ACT and TC was −0.01 (95% CI, −0.14-0.13); for EQ-VAS it was −5.45
(95% CI, −18.61-11.79). The modified CSRI showed a mean difference of 3.28 (95% CI, −14.76-18.61) between ACT and TC at 3 months.
The total cost of the intervention, which included provision of both therapies, mentoring and training over the study duration, was £22 970.
For patients who received ACT, total costs associated with therapy provision were £7820 whereas costs associated with training and mentoring were £2180 and £765, respectively. The cost per participant was £538.25. For TC, the total cost of providing therapy was £10 030, whereas training and mentoring costs were £1920 and £255, respectively. The cost per participant was £554.77, which is slightly higher than ACT because of the higher session uptake (26 sessions more than ACT).
This cost is hypothetical; however, as were a talking treatment of this nature scaled up, it would not be delivered by such a skilled or costly therapist.
3.5 | Sources of bias
| Assessment of blindness
The researchers correctly guessed the participants' group allocation on 65% (11/17) of occasions at 3 months, and 73% (11/15) of the time at 6 months. This suggests some degree of unblinding at 3 months.
| Other treatments used
At 3 months in the ACT group, 4/7 (57%) participants had received psychological therapy, 4/7 (57%) complementary therapy, and 4/7 (57%) attended the gym. In TC, 1/11 (10%) received psychological therapies, 7/11 (70%) received complementary therapies, and 6/11 (60%) attended the gym.
| CONCLUSIONS
It is feasible to recruit people with advanced cancer into a trial of ACT versus TC. Participants engaged well with therapy; of those who attended at least one session, 10/16 (63%) went on to be fully engaged in ACT (ie, attend seven-eight sessions). Moreover, participants reported satisfaction with the intervention they received. However, completion of the main outcome at the primary endpoint (3 months) was low. This finding suggests that participants from a palliative care population found ACT highly acceptable, but researchers should focus on reducing the burden of research and therefore increasing the feasibility of this research.
The main strength of this study was the high engagement of participants in the therapy sessions. Furthermore, recruitment was acceptable, possibly because interventions were offered to all participants. To increase recruitment rates, we suggest broadening the target population to include people receiving palliative care for all diagnoses.
As ACT does not aim to restore full function, but rather helps people cope with dysfunction, it may offer promise to people with chronic, life-threatening physical disease. Although participants engaged well with therapy, their completion of the FACT-G was inconsistent, largely because of ill health at the time of data collection. We have therefore been cautious not to interpret or extrapolate these findings for comparison with other studies.
| Study limitations
A weakness of this study was participants often declined to complete the follow-up assessments. High attrition is a common issue in palliative care, 24 and future research should focus on ways to increase retention. Twelve percent of participants died during their first 3 months in the trial. Whilst theoretically, retention could be enhanced by recruiting people with a better estimated prognosis, in reality,
clinicians are poor at predicting outcome. 25 We suggest it may be more beneficial to limit the number of outcome measures and follow-up time points in a future trial based on the participant feedback received. In particular, the physical outcome measures were unacceptable for this population and could be omitted. Whereas, a main outcome measure like the FACT-G provides an acceptable measure of functioning in several domains in this population. More flexibility around the timing of follow-ups would allow for the challenges raised by the unpredictable course of advanced illnesses.
This study used a TC to control for non-specific therapy factors.
Future research should test the effectiveness of ACT against treatment as usual. Furthermore, we collected data at baseline on participants' expectation of change were they to receive ACT; in hindsight, to allow comparison of both groups, participants' expectations with TC should also have been recorded. Lastly, we aimed to rate the fidelity of the therapy sessions but because of cost constraints this was not possible.
| Clinical and research implications
Our two measures of ACT processes suggested that compared with a normal population, the sample had higher levels of experiential avoidance, psychological inflexibility, and were less able to act in accordance with what is important to them (values), 20, 21 which is consistent with the rationale for using ACT in a palliative population.
Psychotherapies can only be beneficial if participants choose to engage with them. 26 The 
